Athersys
ATHX
#10562
Rank
A$1.26 M
Marketcap
A$0.02042
Share price
-33.50%
Change (1 day)
-98.97%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-46.26%
2022 -A$0.12 Billion-11.54%
2021 -A$0.14 Billion11.14%
2020 -A$0.12 Billion72.2%
2019 -A$68.82 Million77.29%
2018 -A$38.82 Million-22.91%
2017 -A$50.36 Million111.89%
2016 -A$23.77 Million-8.52%
2015 -A$25.98 Million-40.81%
2014 -A$43.9 Million18.62%
2013 -A$37.01 Million
2011 -A$20.85 Million19.71%
2010 -A$17.42 Million-26.28%
2009 -A$23.63 Million-18.21%
2008 -A$28.89 Million-8.28%
2007 -A$31.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.47 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.93 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.15 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.76 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$49.01 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.25 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.95 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.93 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.76 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France